H.C. Wainwright initiated coverage on Bicara Therapeutics with a new price target
Stocks in this Quantisnow insightHealth Care
Keep researching BCAX
- What is Initiation of coverage?The first research report an analyst or brokerage publishes on a company, setting an opening rating and price target.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- BCAX insider tradesEvery buy and sale reported by Bicara Therapeutics Inc. officers, directors and large holders.
- BCAX earnings historyPast Bicara Therapeutics Inc. earnings releases, newest first.
- BCAX financial statementsRevenue, profit, cash flow and balance sheet from Bicara Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
BCAX
Bicara Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2024
Get push alerts for BCAX
Full BCAX profile on Quantisnow Follow BCAX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time